We greatly appreciate all of our Sponsors!
Support our Sponsors as they Support our Organization!
Arcutis Biotherapeutics champions innovation that addresses unmet patient needs—solving the everyday medical dermatology challenges that significantly impact patients and their families. With a passion for understanding what really matters to patients and healthcare providers, Arcutis leverages extensive dermatology development expertise to meaningfully advance the treatment of immune-mediated skin diseases.
This expertise, along with Arcutis’ focus on biologically validated targets and its unique dermatology drug development platform, prepares the company to tackle topical treatment innovation. Founded in 2016 by a leadership team with deep dermatology and commercialization experience—including 50+ FDA-approved products among them—Arcutis features 5 dermatology clinicians on staff.
BioTek reMEDys is a leading specialty pharmacy delivering exceptional service at an affordable cost through comprehensive clinical programs, supply chain management efﬁciencies, and cutting-edge technology. By servicing very speciﬁc disease states, our expert team can focus on patient care, making sure that treatment protocols are appropriate.
Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.
Learn more at www.boehringer-ingelheim.com
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.
In 2021 and 2022 Incyte Dermatology launched a topical treatment for atopic dermatitis and nonsegmental vitiligo, respectively. To learn more, visit ADtreatment.com or treatvitiligotoday.com
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 108,000 people of more than 140 nationalities work at Novartis around the world. Find out more at https://www.novartis.com/us-en/
Regeneron is a leading biotechnology company that invents medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments, almost all of which were homegrown in our laboratories.
Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation around the globe.